IRCT20180425039418N4RecruitingPhase 2
Evaluation of effectiveness of Sertraline and supportive psychotherapy on anxiety and depression level of Leukemia patient referring to clinic of Ali-ibn-Abitaleb Hospital in Zahedan
Zahedan University of Medical Sciences0 sites60 target enrollmentStarted: TBDLast updated:
Trial Snapshot
- Phase
- Phase 2
- Status
- Recruiting
- Sponsor
- Enrollment
- 60
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 18 years to 64 years (—)
- Sex
- All
Inclusion Criteria
- •The age range of patients is between 18 to 64 years old
- •The patients were administered with the definite diagnosis of leukemia by the specialist
- •All the patients should fill up the written consent and give it to the researchers for attending the study
- •The education level of the patients is at least from elementary
- •The patients don't have any history of other medical or psychological disorders
- •The patients don't have any history of drug consumption except smoking
Exclusion Criteria
- •The patient doesn't intend to attend the study
- •The patient has a history of allergy to Sertraline
Investigators
Similar Trials
Recruiting
Phase 3
Comparison of the effectiveness of sertraline and Nortriptyline on anxiety and gastrointestinal symptoms in patients with irritable bowel syndromeIrritable bowel syndromeIRCT20190618043934N13Birjand University of Medical Sciences192
Completed
Phase 3
Sertraline and Fluoxetin in Diabetic Patients with DepressioDiabetes Mellitus.Diabetes mellitus due to underlying conditionIRCT20150630022991N9Babol University of Medical Sciences40
Not yet recruiting
Phase 2
Comparison of the effect of sertraline and midodrine in improving blood pressure during hemodialysisHypotension of hemodialysis.Hypotension of hemodialysisI95.3IRCT20100102002954N29Shahroud University of Medical Sciences82
Recruiting
Not Applicable
Comparison of therapeutic effect of sertraline and supportive psychotherapy in comparison with placebo in coronary heart disease patients with mild to moderate depressioCondition 1: Depression. Condition 2: Mild Depression. Condition 3: Moderate depression.F32 Depressive episode In typical mild, moderate, or severe depressive episodes, the patient suffers from lowering of mood, reduction of energy, and decrease in activity. Capacity for enjoyment, interest, and concentration is reduced, and marked tireF32.0 Mild depressive episode Two or three of the above symptoms are usually present. The patient is usually distressed by these but will probably be able to continue with most activities.F32.1 Moderate depressive episode Four or more of the above symptoms are usually present and the patient is likely to have great difficulty in continuing with ordinary activities.IRCT20171105037241N2Zahedan University of Medical Sciences90
Recruiting
Phase 4
efficacy of sertraline, escitalopram in treatment of depression in patients undergoing chronic hemodialysisIRCT20210424051066N1Shahid Beheshti University of Medical Sciences132